Results 201 to 210 of about 3,725 (244)
Some of the next articles are maybe not open access.
Electroencephalographic analysis of the central action of dihydroxyphenylalanine
Electroencephalography and Clinical Neurophysiology, 1970Abstract 1. 1. The EEG effects of DOPA were analysed in cats, depending upon the level of brain-stem section. 2. 2. In contrast with cats with chronically implanted electrodes, gallamine-immobilized, and with encephale isole cats, in which DOPA is unable to induce profound changes in the EEG pattern and behaviour, this amino acid elicits an
K, Kadzielawa, E, Widy-Tyszkiewicz
openaire +2 more sources
Chemischer Informationsdienst, 1977
Abstract3,4‐Dihydroxy‐benzoesäureester (I) liefert mit Diphenyldichlormethan den cyclischen Ester (II), der nach Reduktion zum Carbinol (IIIa) ein Benzylchlorid (IIIb) gibt, das mit dem Acetylen‐imin (IV) zu einem Substitutionsprodukt (V) führt.
D. TAUB, A. A. PATCHETT
openaire +1 more source
Abstract3,4‐Dihydroxy‐benzoesäureester (I) liefert mit Diphenyldichlormethan den cyclischen Ester (II), der nach Reduktion zum Carbinol (IIIa) ein Benzylchlorid (IIIb) gibt, das mit dem Acetylen‐imin (IV) zu einem Substitutionsprodukt (V) führt.
D. TAUB, A. A. PATCHETT
openaire +1 more source
Syntheses of α-ethynyl-3, 4-dihydroxyphenylalanine and α-vinyl-3, 4-dihydroxyphenylalanine
Tetrahedron Letters, 19773,4-Dihydroxy-benzoesaureester (I) liefert mit Diphenyldichlormethan den cyclischen Ester (II), der nach Reduktion zum Carbinol (IIIa) ein Benzylchlorid (IIIb) gibt, das mit dem Acetylen-imin (IV) zu einem Substitutionsprodukt (V) fuhrt.
D. Taub, A.A. Patchett
openaire +1 more source
The Cerebral Metabolism of L-Dihydroxyphenylalanine
Pharmacology, 2008The regional cerebral distribution of carbon-14 activity was studied using auto-radiography following the intravenous administration of L-3,4-dihydroxyphenyl-(3-14C)-ala-nine (14C-L-dopa) to rats pretreated with carbidopa. 5 min after 14C-L-dopa administration, the regional cerebral distribution of carbon-14 varied with regional cerebral blood flow ...
M.K. Horne, C.H. Cheng, G.F. Wooten
openaire +1 more source
The action of L‐dihydroxyphenylalanine in patients receiving nialamide
Clinical Pharmacology & Therapeutics, 1965Nialamide produces effective monamine oxidase inhibition resulting in a three‐ to fivefold increase in tryptamine excretion when administered in a dose of 100 mg. for 10 days. L‐Dihydroxyphenylalanine, given in a dose of 75 to 100 mg. to normal volunteers receiving nialamide in a dose of 100 mg.
D G, FRIEND, W R, BELL, N S, KLINE
openaire +2 more sources
Stability of collagen in the presence of 3,4-dihydroxyphenylalanine (DOPA)
Journal of Photochemistry and Photobiology B: Biology, 2009Many cross-linking agents for collagen are available with varying levels of toxicity and some are in use in biomedical implants of collagen. L-DOPA (3,4-dihydroxyphenylalanine), a neurotransmitter, is a naturally present compound in the living system and is the target in therapeutic strategy of Parkinson's disease.
R, Usha, A, Rajaram, T, Ramasami
openaire +2 more sources
ADMINISTRATION OF DIHYDROXYPHENYLALANINE TO PARKINSONIAN PATIENTS.
Canadian Medical Association journal, 1996Dihydroxyphenylalanine (dopa), the metabolic precursor of dopamine, was administered to 10 parkinsonian patients in oral doses of 1-5 g. and intravenous doses of 0.2-0.5 g. Increases in dopamine excretion of 100- to 1000-fold following the dopa administration indicated that dopa was being absorbed and metabolized. Only two of the 10 patients showed any
P L, MCGEER, L R, ZELDOWICZ
openaire +1 more source
Excretion of 3,4-dihydroxyphenylalanine in urine
Biochimica et Biophysica Acta (BBA) - General Subjects, 1961T, GERRITSEN, S C, COPPS, H A, WAISMAN
openaire +2 more sources
Remission in dihydroxyphenylalanine‐responsive dystonia
Movement Disorders, 1995M, Di Capua, E, Bertini
openaire +2 more sources

